Halozyme Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.08.17	Halozyme Reports Second Quarter 2017 Results (PR Newswire)
04.08.17	Halozyme Therapeutics To Present At Upcoming Healthcare Conference (PR Newswire)
19.07.17	HaloSource Secures $2.2 Million in Funding to Accelerate Drinking Water Market Presence (PR Newswire)
13.07.17	Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy (PR Newswire)
10.07.17	Halozyme To Host Second Quarter 2017 Financial Results Conference Call (PR Newswire)
22.06.17	FDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE Technology (PR Newswire)
04.06.17	Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO (PR Newswire)
25.05.17	Halozyme Therapeutics To Present At Upcoming Healthcare Conferences (PR Newswire)
24.05.17	Halozyme Therapeutics Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares (PR Newswire)
19.05.17	Halozyme Therapeutics Posting Steep Loss After Initial Sell-Off (RTTNews)
19.05.17	Halozyme Therapeutics Prices Public Offering Of Common Stock (PR Newswire)
18.05.17	Halozyme Therapeutics Announces Public Offering Of Common Stock (PR Newswire)
13.04.17	Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma (PR Newswire)
10.04.17	Halozyme To Host First Quarter 2017 Financial Results Conference Call (PR Newswire)
03.04.17	Halozyme's PEGPH20 Increases Immune Response and Effectiveness of Immunotherapies in Preclinical Cancer Models (PR Newswire)
31.03.17	Gainers & Losers Of Mar.30: XBIO, PRAN, AKER, TNXP, HALO... (RTTNews)
30.03.17	Halozyme Provides Update On SWOG Collaborative Group Clinical Study (PR Newswire)
30.03.17	FDA Snubs MYL, Roche Wins FDA Panel Vote Hands Down, TNXP Falls After-hours (RTTNews)
29.03.17	FDA Advisory Committee Provides Unanimous Recommendation For Subcutaneous Rituximab Coformulated With Halozyme Enhanze Technology (PR Newswire)
02.03.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, CytRx, Cara Therapeutics, and Keryx Biopharma (PR Newswire)
28.02.17	Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results (PR Newswire)
13.02.17	MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20 (PR Newswire)
20.01.17	Worthy Start of the Year for Biotech Companies (PR Newswire)
16.01.17	Statement by Peabody Energy (PR Newswire)
12.01.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, Keryx Biopharma, Curis, and Agios Pharma (PR Newswire)
09.01.17	Halozyme Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare Conference (PR Newswire)
06.01.17	Stock Reports for Halozyme Therapeutics, Alibaba, Kohls, Macy's Incorporated and Sprint Corp include trade ideas with returns over 18% (PR Newswire)
06.01.17	OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC (RTTNews)
06.01.17	Gainers & Losers Of The Day: ETRM, PIRS, GNVC, AEZS, XXII (RTTNews)
05.01.17	Halozyme Posting Strong Gain On Positive Clinical Trial Results (RTTNews)
05.01.17	Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints (PR Newswire)
29.11.16	View Dynamic Glass Unveiled at San Leandro Tech Campus (PR Newswire)
21.11.16	Halozyme Provides Update On AbbVie Collaboration (PR Newswire)
11.11.16	ANTH Plunges As Lupus Trial Fails, BMY's Opdivo Is At It Again, FDA Nod For GILD (RTTNews)
22.01.16	AMGN Gets FDA Nod, Data Awaits RGLS In Feb, FORWARD Puts ALKS On The Back Foot (RTTNews)
21.12.15	Halozyme Enters Into Global Collaboration And Licensing Deal With Lilly (RTTNews)
05.06.15	Halozyme CFO David Ramsay To Retire; Laurie Stelzer Named Successor (RTTNews)
04.06.15	BLUE, CELG Fine Tune Deal, Lightlake Cruises Ahead, HALO Shines, CPXX On Track (RTTNews)
28.05.15	FDA Approves IBS-D Drugs, GBIM Plunges On Hepatitis B Drug Data, RTRX On A High (RTTNews)
27.05.15	Halozyme, Ventana To Develop Companion Diagnostic Assay For Use With PEGPH20 (RTTNews)
09.04.15	BONE Bows Out Of Big Board, HALO Shines, MabVax On Watch, TRIV Revises Outlook (RTTNews)
11.11.14	Halozyme Therapeutics Plunge 12% As Q3 Results Miss Estimates (RTTNews)
10.11.14	Halozyme Loss Wider Than Estimate, Revenue Misses; Stock Down 8% (RTTNews)
07.10.14	Halozyme Therapeutics Announces Issuance Of New U.S. Patent - Quick Facts (RTTNews)
03.10.14	FDA Grants Orphan Drug Designation For Halozyme's PEGPH20 - Quick Facts (RTTNews)
18.09.14	Halozyme Therapeutics : SWOG To Resume Trial In Advanced Pancreatic Cancer Drug (RTTNews)
13.09.14	FDA Okays Baxter's Hyqvia To Treat Adults With Primary Immunodeficiency (RTTNews)
12.08.14	Halozyme Therapeutics Q2 Loss Narrows, Results Beat View (RTTNews)
11.08.14	Halozyme Therapeutics Q2 Loss Narrows - Quick Facts (RTTNews)
05.06.14	HALO Brightens, CPXX Eyes Long Haul, LJPC Awaits Next Catalyst (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Halozyme Therapeutics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten